Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Clinterooon Mar 21, 2011 8:30pm
346 Views
Post# 18319027

RE: RE: RE: RE: RE: Some calculations

RE: RE: RE: RE: RE: Some calculationsI have looked at the companies that Burton Bloom and have done this for and some go up and some go down. For RVX it was done at $3.23 and share price is now $1.78. Of course there are ones that have gone up.

It is more the fundamentals of the company and not just doing a financing with Bloom Burton.

As for the market cap, you conveniently pick the high of the year. Market cap is just a reflection on share price. It can go up or down for seemingly no reason. Obviously the market thinks a market cap of $100 million for this company is very excessive... otherwise it would be back up there.

As for the average market cap, that is a funny argument. A quick look shows the market cap of Paladin is $700 million and ONC is $400 million. You think these might skew the averages???? This average of $187 million doesn't seem so impressive when these two are taken into account.

Anyway, hopefully we hear the details tomorrow and hopefully it is at a good price. I doubt it is as good as
.15 per unit... depends on the warrants on what portion it gives them. We shall see.
Bullboard Posts